Ensemble Therapeutics Corporation to Present at 2012 American College of Rheumatology Annual Meeting

Published: Oct 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble Therapeutics, a biotechnology company developing EnsemblinsTM, a novel class of small molecule therapeutics with the power of biologics, announced today that a poster presentation on its orally active small molecule antagonists of Interleukin-17 has been selected for presentation at the American College of Rheumatology (ACR) 2012 Annual Meeting taking place November 9-14, 2012 in Washington, DC.

Back to news